This conjugate displayed a higher cytotoxic activity against the PR(+) MCF-7 breast cancer cell line (IC50 = 4.5 μM) compared to the PR(−) MDA-MB-231 cells (IC50 = 20.7 μM, selectivity index = 4.5). Here, PGR is linked to breast carcinoma.